Results: MiR-29a was repressed by androgen system and inversely inhibited AR expression by targeting IGF1 and CDC42/p85α-p53 pathway in mouse epididymis.
Conclusion:
There is an androgen receptor-miR-29a regulatory circuitry in mouse epididymis.
Significance:
The mutual repression between miR-29a and AR may be important for epididymal development and functions.
MicroRNAs are involved in a number of cellular processes, thus their deregulation is usually apt to the occurrence of diverse diseases. Previous studies indicate the abnormally up-regulated miR-29a is associated with several diseases, such as human acute myeloid leukemia and diabetic, therefore, the proper level of miR-29a is critical for homeostasis. Herein, we observed that miR-29a was repressed by androgen/androgen receptor (AR) signaling in mouse epididymis by targeting a conserved androgen response element (ARE) locating 8 kb upstream of miR-29b1a loci. It is well known that multiple regulatory programs often form a complicated network. Here, we found miR-29a reversely suppressed androgen receptor and its targeting genes by targeting IGF1 and p53 pathways. MiR-29b1a overexpression transgenic mouse displayed a hypoplasia epididymis, partially similar to the phenotype of those mice with impaired androgen-androgen receptor signal system. Taken together, the results demonstrated there was a regulatory circuitry between androgen signaling pathway and miR-29a in mouse epididymis, which may vital for epididymal development and functions. microRNAs (miRNAs) are a class of endogenous, 20-23 nucleotides, small non-coding RNAs and serve as post-transcriptional regulators of gene expression (1) . miRNAs are involved in a variety of cellular processes and organ development through regulating a large number of genes (2) . Consistently, the deregulation of miRNAs frequently links to distinct diseases (3) (4) (5) . Therefore, the proper regulation of miRNAs in physiological state is important.
Our and other previous studies reveal miR-29a is up-regulated during postnatal development of many organs, such as heart, liver, lung, epididymis, aorta, brain, cornea, and skeletal muscle, then maintains in a high level in adult stage (6) (7) (8) (9) (10) (11) . However, abnormally elevated miR-29a level is associated with several diseases. For example, miR-29a increases in muscle, adipose tissue, and liver of diabetic rats, and up-regulation of miR-29a causes insulin resistance in adipocytes (12) . Recently, Han et al. observe that a significant proportion of human acute myeloid leukemia exhibit enhanced miR-29a expression and suggest that miR-29a may also play a role in human myeloid leukemogenesis (13) . In addition, miR-29a expression is greatly enhanced in patients with invasive breast carcinomas compared with non-invasive hyperplasias (14) . All these data indicate that abnormal up-regulation of miR-29a is harmful, thus the miR-29a expression should be properly suppressed.
Indeed, previous studies reveal that miR-29a is suppressed by multiple factors, such as TGF-beta/Smad3, c-Myc, Hedgehog, and NF-kappaB signaling pathway (15) (16) (17) (18) . In male reproductive system, especially in epididymis, androgen pathway plays very important regulatory roles in their development, functions, gene expression, and even miRNA expression. For example, miR-125b, miR-99a, and miR-100 are suppressed by androgen/AR in LNCaP prostate cancer cells (19) . In addition, using the analysis of chromatin immunoprecipitation followed by sequencing (ChIP-Seq), we discovered an AR binding site (ARBS) locating at 8 kb upstream of miR-29b1a loci in mouse caput epididymis (unpublished data). All these evidences suggest that miR-29b1 and miR-29a may be involved in androgen signaling pathway in male reproductive system. Epididymis, a highly androgen-sensitive organ responsible for sperm maturation and storage, was employed here to test this possibility by using castration model. Our results showed that miR-29a was repressed by androgen/AR in mouse epididymis. Disruption of the repression by over-expressing miR-29a in transgenic mice resulted in a hypoplasia epididymis. Furthermore, elevated miR-29a expression can reversely suppress AR expression by targeting IGF1 and CDC42/p85α-p53 pathways. Taken together, our results demonstrated there was a regulatory circuitry between androgen/AR signaling pathway and miR-29a, which may be important for epididymal development and functions. bovine serum (FBS), 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 4 mM glutamine, penicillin-streptomycin (25000 U penicillin G sodium, 25 mg streptomycin sulfate), and 1 nM 5α-dihydrotestosterone (DHT) (20) . The MCF-7 and HEK 293T cells were maintained in DMEM media; LNCaP, RM-1, U-2 OS, and T24 cells were maintained in RPMI-1640 medium supplemented with 10% (v/v) FBS; MG-63 cells were maintained in MEM medium supplemented with 10% (v/v) FBS; RWPE-1 cells were maintained in keratinocyte SFM medium. All these cells cultured at 37℃ with 5% CO 2 . All the cell culture reagents were purchased from Invitrogen-Life Technologies (Carlsbad, CA). For androgen deprivation, cells were plated in the medium supplemented with 10% charcoal-stripped serum (Hyclone) 24 h before treatment with 5α-DHT. Vehicle was ethanol. The IGF1 protein was purchased from ProSpec company (Cat. No. CYT-216).
Castration
and androgen replacement-Castration and androgen replacement were conducted following a previously described protocol (21, 22) . Briefly, mouse castration model as following: adult 10-wk-old male C57BL/6 mice were castrated bilaterally under sodium pentobarbital anesthesia. The mice were divided into three groups (six mice per group), killed at different times after castration (0, 2 d after the initial testosterone propionate (TP, 2.5 mg/kg body weight) or sesame oil injections (at 7d after castration). For rat castration model, the 120-day-old normal male Sprague Dawley rats were divided into nine groups (4-7 rats per group) and killed on days 1, 3, 5, and 7 after castration as well as 1, 3, 5, and 7 days after the initial TP injection. Androgen supplementation began at the seventh day after castration, and the rats were injected with TP ( 3 mg/kg body weight) every 2 days. The epididymidis, prostate, brain were excised and used for RNA extraction. 5'-GTgcggccgcACGGACTTCACCTTCCCT-3' (NotⅠ) and reverse: 5'-GAgagctcGTCAGCAATAACGTAGTCAG-3' (SacⅠ). The 541-bp product was digested with restriction endonuclease NotⅠand SacⅠ, and then cloned into the expression vector pUBC containing a human ubiquitin-C promoter, which was found to provide the most reliable expression across different cell types. After testing the efficacy of miR-29a and miR-29b over-expression in HEK 293T cells, the construct was linearized for pronuclear microinjection.
Northern blotting-The
Real-time RT-PCR-Quantitative real-time RT-PCR was performed to detect mRNA expression using Toyobo SYBR Green Real-time PCR Mix (Toyobo, Osaka, Japan) according to the manufacturer's protocol. Levels of mRNAs were normalized to GAPDH. The primers were as following: Mouse AR,
miRNAs, small interfering RNAs, and Transfection-RNA oligonucleotides were transfected into cells using RNAiMAX (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. MiR-29a and miR-29b duplex (pre-miR-29a, pre-miR-29b) or miR-29a specific inhibitor (anti-miR-29a) molecules and appropriate negative control molecules (pre-miR-negative control, pre-miR-NC; or anti-miR-negative control, anti-miR-NC) were purchased from Ambion (Austin, TX). Small interfering RNAs (siRNA) were synthesized by GenePharma (GenePharma, Shanghai, China): IGF1 siRNA-1: 5'-CAGCCUUCCAACUCAAUUATT-3', IGF1 siRNA-2: 5'-GUGACUUCUUGAAGAUAAATT-3'; and p53 siRNA was:
Western blotting-Proteins were extracted from cells using RIPA buffer (25 mM Tris, pH 7.4, 150 mM NaCl, 1% (v/v) NP-40, 1% (w/v) sodium deoxycholate, 0.1% (w/v) SDS). Each protein sample (30~50 μg) was separated by 10% SDS-polyacrylamide gels (for AR and p53) or 15% SDS-polyacrylamide gels (for IGF1), and then semi-dry blotted to polyvinylidene difluoride membranes (Amersham Pharmacia Biotech, Piscataway, NJ). Immuno-detection of proteins was carried out by standard procedures using rabbit polyclonal antibody （Ab） to AR (Santa Cruz Biotechnology, Santa Cruz, CA, 1:500 dilution), IGF1 (ABCAM, 1:500 dilution), and p53 (ABCAM, 1:500 dilution). The protein blot were probed with primary antibody and goat anti-rabbit secondary Abs conjugated to HRP (Sigma-Aldrich, St. Louis, MO) and detected using ECL (GE, Piscataway, NJ) reagents. β-actin (Santa Cruz Biotechnology, Santa Cruz, CA) was used as a loading control.
DNA constructs and mutagenesis-792-bp
AR-binding regions around the peak summit was amplified with primer-1, 5'-gaggtaccTCCCATGTCTTTGACTTGATTTT C-3' (Kpn Ⅰ ) and primer-2, 5'-gaactcgagGCTCGCCCTTTGAGAAACATT-3' (XhoⅠ), and subcloned into pGL3-Basic and pGL3-Promoter luciferase reporter vectors. The ARE mutated with primer 1, primer 2, primer 3 (5'-TTCAGGGCCTGAGTAGATAGATGT-3'), primer 4 (5'-TAAGAACATGGCTCAATTCTTTTTC-3'), and primer 5 (5'-TACTCAGGCCCTGAAtTAaAGCATaTTt TAAGAACATGGCTCA-3').
Briefly, the upstream of ARBS fragment was amplified using primer 1 and primer 3, the downstream of ARBS fragment was amplified using primer 2 and primer 4, and then amplified the full-length mutated ARBS using primer 1, primer 2, and primer 5 with the upstream and downstream as template. Then the product was cut with KpnⅠ and XhoⅠand liganded with pGL3-Promoter luciferase reporter vectors. HEK 293T cells were grown in 96-well plates, cotransfected with 150 ng reporter constructs, 15 ng pRL-TK (Renilla luciferase), and 15 ng pcDNA3.1-AR expression vector coding for full-length human AR using X-tremeGENE HP DNA Transfection Reagent (Roche). After 12 hours transfection, cells were treated with 100 nM dihydrotestosterone or ethanol vehicle for 24 h. Luciferase activity was measured using the dual-luciferase reporter assay (Promega, Madison, WI) and Mithras LB940 multimode microplate reader (Berthold, Bad Wildbad, Germany).
The three prime untranslated regions (3'UTR) of the human IGF1 were amplified using the primers 5'-CCGctcgagTCCATCTGTGGCATTTGTACC -3' (Xho I) and 5'-GTAgcggccgcCCCTTGTGTCATCTTTGGC TCC-3' (Not I). After cut with Xho I and Not I, the amplified products were subcloned to downstream of the Renilla luciferase gene of the psiCHECK™-2 plasmid (Promega，Madison, WI). The site-directed mutagenesis was performed using Quick-Change Site-Directed Mutagenesis kit (Stratagene, Santa Clara, CA).
The primers for mutation of the target site of human IGF1 3'UTR were 5'-GTAAAACTCTGTTTTTTAGTATAATGGG TAGATTTTGTAGTTTGTTATATGAAAGAGT C-3' (forward), and 5'-GACTCTTTCATATAACAAACTACAAAA TCTACCCATTATACTAAAAAACAGAGTTT TAC-3' (reverse). Four nucleotides TGCT in "seed" sequences of miR-29a potential target site were mutated to GTAG（underlined）.
Luciferase reporter assay-HEK 293T cells were seeded to 24-well plates 24 h before transfection. HEK 293T cells were transiently transfected with 100 ng of psiCHECK™-2 (Promega Madison, WI) vector containing the wild-type IGF1 3'UTR (named as IGF1-3'UTR-WT) or IGF1 3'UTR mutant (named as IGF1-3'UTR-Mut), and together with 30 nM pre-miR-29a or pre-miR-NC, respectively. By using dual-luciferase assay kit (Promega Madison, WI), the luciferase activities were measured 24 h after transfection. The renilla luciferase activity was normalized to firefly activity. Lipofectamine 2000 transfection reagent was used for co-transfection of RNA oligonucleotides and plasmid.
Hematoxylin and Eosin (HE) Staining and
Immunohistochemical Staining-HE staining of the sections was carried out using standard protocols. Immunohistochemical staining was performed as described previously (23) . Primary and secondary antibodies were diluted in PBS containing 10% normal goat serum. The 1: 100-diluted anti-AR antiserum (Abcam, Cat. No. ab74272, Cambridge, UK) was applied to the tissues overnight at 4℃ and the 1: 200-diluted biotin-conjugated goat anti-rabbit IgG was incubated for 1 h at room temperature. The expression was visualized using horseradish peroxidase (HRP) substrate. As a negative control, serial sections were subjected to the same procedure, with normal rabbit serum replacing the primary antibody. The expression was visualized using horseradish peroxidase (HRP) substrate. The sections were mounted in 80% glycerol and examined with an Olympus BX-52 microscope.
In Situ Hybridization-In situ hybridization was performed as described previously (24) . Briefly, the epididymal tissues were fixed in 4% paraformaldehyde (PFA), and then embedded in paraffin. The embedded epididymidis were sectioned. The slides were dewaxed, then digested with Proteinase K (500 ng/ml), hybridized with locked nucleic acid (LNA) probes (Exiqon) special for mmu-miR-29a, U6 snRNA and a scramble oligonucleotides, which were labeled with digoxigenin (DIG). The temperature of hybridization was 65 ℃ . The expression of miR-29a or control small RNAs was visualized using alkaline phosphatase substrate.
TUNEL assay-The TUNEL assay was performed as the protocol of in situ apoptosis detection kit (Takara Bio Inc., Shiga, Japan). In short, after deparaffinization and rehydration, the 5 μm paraplast tissue sections were incubated with 20 μg/ml Proteinase K solution (Invitrogen/Gibco/MP, Cat. No. 25530049) for 15 min at 37 ℃ . Thereafter, sections were incubated with FITC-labeled terminal deoxynucleotidyl transferase. Next, sections were rinsed in PBS and observed under a fluorescence microscope.
RESULT
Androgen negatively regulates miR-29a expression in epididymis-Androgen acts through its receptor, AR, to control normal development of male reproductive organs and maintain male characteristics. Orchiectomy is considered as an ideal model to investigate androgen effects, for example, its regulation on gene expression. Therefore, herein castration model was used to investigate the response of miR-29a to androgen manipulation. Firstly, we found that the level of miR-29a was higher in the mouse epididymis at 9-day after orchiectomy (after castration 7d with sesame oil injection for 2-day) than in normal epididymis. MiR-29a level in sesame oil injection group was also higher than TP injection group (Fig. 1A,  left panel) . These results strongly demonstrated that miR-29a level was revered with androgen level (Fig. 1A) . Subsequently, similar phenomena were observed in rat epididymis by using castration model (Fig. 1B) . After castration, the ratio of epididymal cell types may be altered because cell apoptosis occurred and mainly occurred in principle cells (25) . In order to exclude the possibility of the change of miR-29a caused by the altered ratios of cell types in the castrated epididymis, we investigated miR-29a expression pattern in normal rat epididymis using in situ hybridization. The result showed that miR-29a was extensively expressed in epididymal epithelial cells (Fig. 1C) . Thus, the change of miR-29a mainly caused the regulatory effects. Further, we tested whether miR-29a was androgen-responsive in principal cells using an in vitro system. PC-1 cell line, an immortalized epididymal principal cell line from mouse proximal caput was employed here. PC-1 cells were maintained in IMDM medium with different concentrations of DHT. Twenty four hours later, miR-29a expression was determined using Northern blotting. The expression of miR-29a in PC-1 cells cultured without DHT was higher than with DHT. Furthermore, the level of miR-29a displayed a dosage-dependent pattern (Fig. 1D) , which also further validated that the up-regulation of miR-29a in castrated epididymis was not the consequence of the alteration of cell type ratios, but the alteration of androgen level. Thus, miR-29a was an androgen-repressive miRNA in mouse and rat epididymis.
miR-29b1, another member of miR-29 family, is in close proximity to miR-29a on mouse chromosome 6 (26) . So, we detected the response of miR-29b to androgen. Similarly, miR-29b was also suppressed by androgen (Fig.  1E ). In conclusion, miR-29b1/a cluster was repressed by androgen signaling system. Differently, Ribas et al. found that miR-29a may be one of AR-induced miRNAs in two human androgen-responsive prostate cancer cell lines LNCaP and LAPC-4 by miRNA microarray analysis (27) . To validate this result, LNCaP cells were plated in medium with 0 to 10 nM of DHT, and 72 hours later, the cells were harvested to detect miR-29a level. The result showed that miR-29a was indeed induced by androgen in LNCaP cells ( Fig. 2A) , which differed from in epididymal cells. Hereupon, we were evoked by the question whether miR-29a was suppressed by androgen specifically in epididymis. To answer this question, we further investigated miR-29a expression in prostate and brain in castrated mouse. Consequently, the expression of miR-29a was repressed by androgen stimulation in mouse prostate tissue, while in brain there was no apparent change ( Fig. 2B and C) . Therefore, the repression of miR-29a by androgen was not epididymis specific.
Next, we wondered whether the responsive patterns of miR-29a were different between physiological and tumorigenic state. We then investigate the responses of miR-29a to androgen stimulation in mouse prostate cancer cell line RM-1 and normal human prostate epithelial cell line RWPE-1. As a result, miR-29a was also suppressed by androgen in RM-1 cells and RWPE-1, although the change in RWPE-1 cells is weak (Fig. 2E and F) . Furthermore, we also tested the responses of miR-29a to androgen in several human AR-positive cancer cell lines, including MCF-7 cells (breast cancer), U-2 OS, and MG-63 cells (osteosarcoma), and T24 cells (bladder carcinoma). However, there are no apparent changes in these cell lines (Fig. 2G-I) . RM-1 cell lines is androgen-insensitive. Why DHT also inhibit the expression of miR-29a in androgen-insensitive RM-1 cell line? Previous study revealed that DHT treatment of androgen insensitive human prostate cancer cell line PC-3 resulted in upregulation of p21CIP1 levels (28) . Because the AR-mediated trans-activation could be induced in a ligand-independent manner (29, 30) . We deduced that miR-29a was suppressed in RM-1 cells possibly by the similar mechanism, because AR also can be upregulated by DHT stimulation in RM-1 cells ( Figure 2J ). These results indicated that the repression of miR-29a by androgen was context-dependent.
Androgen regulates miR-29b1a through AR binding to upstream of miR-29b1a-Then, we investigated how androgen regulated miR-29a
and miR-29b expression. It is well known that the effects of androgen are mediated through AR binding to ARE DNA (31, 32) . Previously, by ChIP-Seq assay we identified the binding sites of AR in mouse caput epididymis. These binding sites were associated with sixty-three miRNAs, including miR-29a (21) . As shown in Fig. 3A , there was an AR binding site enriched by AR at 8 kb upstream of miR-29a and miR-29b1 precursor. We first confirmed this site was a bona fide AR binding site by ChIP-PCR (Fig. 3B) . Our results showed the peak was androgen-dependent (Fig. 3C) . Next, we performed bioinformatics analysis and found that the binding site contained two conserved AREs (Fig. 3D) . Further experiments by EMSA showed the ARE1 but not ARE2 can be bound by AR (Fig. 3E) . Mutation of ARE1 (Fig. 3D) abolished the binding activity ( Fig. 3F and G) , indicating that androgen regulated miR-29b1a expression through AR binding to a conserved ARE upstream of miR-29b1a.
Then the ARBS was subcloned to pGL3-Basic luciferase reporter vectors. Compared with pGL3-Basic vector, the pGL3-Basic-ARBS did not show apparent increased luciferase activity with DHT stimulation or not (data not shown), indicating the ARBS may be a enhancer/silencer. Next, the ARBS was subcloned to pGL3-Promoter vector. As Fig. 2H showed, the luciferase activity was downregulated after DHT stimulation compared to ethanol control, but the mutation of ARE1 abolished the repressive effect. These results indicated that the ARE1 was a bono fide repressive regulator element on miR-29b1a expression.
Over-expression of miR-29b1a leads to smaller epididymis-As described above, androgen signaling pathway inhibited miR-29b1a expression in mouse epididymis. To further confirm this result in vivo and explore its biological function, we generated miR-29b1a transgenic mice by over-expressing a 523-nt precursor of miR-29b1a under the control of the promoter of ubiquitin-C (UBC) gene (Fig. 4A) . The genotyping of the mice was performed by PCR on genomic DNA (data not shown). MiR-29a and miR-29b expression levels were detected using Northern blotting. As anticipated, there were more miR-29a and miR-29b expression in transgenic mice epididymis compared to their littermates (Fig. 4B) . Consequently, epididymis from transgenic mice displayed small size and weighty ( Fig. 4C and  D) , demonstrating miR-29b1a over-expression disturbed epididymal development. Although the transgenic mice displayed smaller epididymis, but the ratios of cell types showed no apparent change (Fig. 4E) . There was no apparent difference of cell apoptosis in wild type and transgenic mice epididymis, but more apoptotic cells were observed in transgenic mice testis (Fig. 4F) . (33) (34) (35) . We wondered whether miR-29a disturbed epididymal development by inhibiting AR expression. To test this speculation, we detected AR mRNA and protein levels in wild type and transgenic mouse epididymis by using real-time PCR and Western blotting, respectively. As expected, AR level was significantly lower in transgenic mouse epididymis than their non-transgenic littermates ( Fig. 5A and B) . Consistently, AR immunostaining showed a weak signal in transgenic mice epididymis compared to wild type (Fig. 4C ). Next, we tested this reverse suppression in vitro. Pre-miR-29a and scramble RNA oligonucleotides were transfected into PC-1 cells. Forty-eight hours later, RNA and protein were extracted to detect the expression of AR. Compared to scrambled RNA transfection group, the mRNA and protein levels of AR was decreased in pre-miR-29a transfection group (Fig. 4D and E) . Consistently, we found miR-29b can also suppress AR expression in PC-1 cells (Fig. 4F) . Taken together, miR-29b1a suppresses the expression of AR in vitro and in vivo.
Feedback inhibition of AR by miR-29a-It is well known that the epididymis is agenesis in AR knockout mice
Such being the case, miR-29a and miR-29b should also suppress the target genes of androgen signaling pathway. Here, we detected four epididymal androgen-responsive genes, including Adam7, Fkbp5, Gldc, and Gpx5 (36, 37) . There was no any miR-29a and miR-29b binding sites on the 3' UTR of these four genes using online software miRWalk (ww.umm.uni-heidelberg.de/apps/zmf/mirwalk/), indicating that they should not be direct targets of miR-29a and miR-29b. The result showed that these four genes were down-regulated in miR-29b1a transgenic mouse at mRNA level (Fig. 4G) , demonstrating miR-29a and miR-29b down regulated AR expression, and thereby suppressed the activity of androgen signaling in mouse epididymis.
miR-29a represses AR expression through
IGF1 and p53 pathway-Subsequently, we predicted possible miRNAs targeting sites of mouse AR at regions of 5'UTR, coding region, and 3'UTR using online software miRWalk (ww.umm.uni-heidelberg.de/apps/zmf/mirwalk/), and found miR-29a is not a candidate, thus miR-29a regulate AR expression probably in an indirect way. Then, we try to find which genes potentially mediated this regulation. Pervious study revealed that AR protein level is decreased in prostate from IGF1 knockout mice (38) . Therefore, we determined whether IGF1 can also activate AR expression in mouse epididymal cells. At a concentration of 1 ng/ml, IGF1 can apparently promote AR protein level (Fig. 6A ), but slightly decrease AR mRNA level (Fig. 6B ). In consistent with this, after IGF1 being down-regulated by using specific siRNAs (Fig. 6C) , AR protein level was also reduced (Fig. 6D ), but AR mRNA was slightly increased (Fig. 6E) . It is possible that IGF1 signal pathway can weakly inactivate the transcription of AR, but increase the stability of AR protein. Then, we explored whether miR-29a suppressed IGF1 expression. Over-expression of miR-29a by transfection of pre-miR-29a into PC-1 cells suppressed the expression of IGF1 at mRNA and protein levels ( Fig. 6F and G) . Consistently, IGF1 mRNA and protein levels were down-regulated in the epididymis of the miR-29b1a transgenic mice ( Fig. 6H and I) , although the IGF1 level in circulation didn't showed apparent change (data not show). Our results, therefore, confirmed miR-29a suppressed IGF1 expression both in vivo and in vitro.
Further, to know whether IGF1 is a direct target of miR-29a, the dual luciferase reporter assay was performed. Firstly, IGF1 is predicted as a potentially conserved target of miR-29a by using three online softwares: TargetScan, MiRanda, and PicTar (Fig. 6J) . Then, the wild-type or mutated 3' UTR of IGF1 mRNA was cloned to downstream of the Renilla luciferase gene and co-transfected with pre-miR-29a or scrambled oligonucleotides into HEK 293T cells. Luciferase activities were measured 24 h after transfection. As a result, cells co-transfected with the reporter gene carrying wild-type IGF1 3'UTR and pre-miR-29a exhibited apparent reduction of the luciferase activities compared with cells transfected with the scrambled oligonucleotide (Fig. 6K, left) . Then, four nucleotides (TGCT→ GTAG) in "seed" sequences of miR-29a potential target site were mutated. The reduction of luciferase activity of the reporter by miR-29a was abrogated by the mutations (Fig. 6K, right) . These data indicated that the IGF1 3'UTR was truly targeted by miR-29a. Consistently, Hand et al. also demonstrated recently, miR-29 a/b1 can target IGF1 in mouse liver (39) . Taken together, IGF1 was a direct target of miR-29a and it mediated the suppression of AR by miR-29a.
Additionally, Alimirah et al. found p53 can negatively regulate AR expression by binding to a p53 DNA-binding consensus sequence of AR promoter in human prostate cancer cells (40) . Meanwhile, p53 can be induced by miR-29 through targeting CDC42 and p85α (41) . Thus, we deduced miR-29a may repress AR expression by inducing p53 expression in epididymis too. To verify this hypothesis, firstly, we wondered whether miR-29a can also promote p53 expression in epididymal cells. As expected, CDC42 and p85α, which negatively regulated p53 expression (30), were down-regulated in PC-1 cells transfected with pre-miR-29a (Fig.  7A) . Consequently, over-expression of miR-29a in PC-1 cells elevated p53 protein level (Fig. 7B) . Consistently, when miR-29a was inhibited, p53 protein decreased (Fig. 7C) . As expected, CDC42 and p85α mRNA levels decreased (Fig.  7D) , while p53 protein level increased in miR-29b1a transgenic mice epididymis (Fig.  7E) . Thus, miR-29a can also promote p53 expression in mouse epididymis. Secondly, we want to know whether p53 can also inhibit AR expression in mouse epididymis. PC-1 cells were transfected with specific siRNA against mouse p53, and 48 h later, the AR protein level was indeed up-regulated (Fig. 7F) . Therefore, p53 can also served as a mediator of the suppression of AR by miR-29a in mouse epididymis.
In summary, miR-29a and AR were mutually inhibited and formed a regulatory circuitry to regulate epididymal development (Fig. 8) .
DISCUSSION
Androgen and its receptor regulate several miRNA biogenesis in different tissues or cell lines. For example, the expression of miR-21, miR-125b, miR-101, miR-148a, and miR-338 are modulated by androgen/AR in prostate cancer cells (27, (42) (43) (44) (45) . Meanwhile, miR-122 and miR-216a are induced in female mouse liver and hepatocarcinogenesis by androgen (46,47). The facts that androgen is critical for epididymal development and function, and miR-29a plays vital roles in epididymal development and function (3), suggest an androgen regulation of miR-29a in epididymis. Herein, we identified a bona fide ARE upstream of miR-29b1a, and demonstrated that androgen negatively regulated miR-29a in epididymis. Our data first confirmed miR-29a was an androgen repressive miRNA in mouse and rat epididymis as well as in mouse epididymal cell line, and extended the current understanding of miRNAs regulation by androgen under different physiological and pathological states. RM-1 is an androgen-insensitive cell line. But miR-29a was also repressed in RM-1 cell by DHT. Previous study revealed the AR-mediated trans-activation could be induced in a ligand-independent manner (29, 30) . We deduced that miR-29a was suppressed in RM-1 cells possibly by the similar mechanism, because AR also can be upregulated by DHT stimulation in RM-1 cells (Fig. S3K) .
Being the mediator of androgen functions, AR expression is well regulated by some transcriptional factors such as Wnt and NF-κB signaling pathway in prostate cancer cells (48, 49) . Serving as the post-transcriptional regulators, miRNAs can also regulate AR. Previous papers reported that several miRNAs, including miR-488*, let-7c and miR-331-3p down-regulated AR (50) (51) (52) . Our study demonstrated miR-29a and miR-29b regulated AR expression in mouse epididymis. Furthermore, all the previous papers demonstrated that miRNAs inhibited AR at cell level. Our studies provided the first in vivo evidence that miRNAs regulated AR at organism level. Moreover, although androgen is critical for epididymal development and functions, how AR was regulated in epididymis was unclear up to now. This study, obviously, shed new light on the understanding of AR regulation in epididymis.
Androgen repressed miR-29a, and miR-29a down-regulated AR. Thus, there is a regulatory circuitry between miR-29a and AR. The regulatory circuitry fine tuned epididymal development and functions. Once the regulatory circuitry disrupted, epididymis disorders occurred. Our data showed that the expression of miR-29a level was elevated accompanying with androgen withdraw after castration. It has been reported miR-29a can induce cell apoptosis by targeting multiple genes (34) (35) (36) . Thus, the castration-mediated miR-29a elevation might contribute to apoptosis of epididymal epithelial cells. Meanwhile, elevated miR-29a suppressed AR expression and deteriorated castration effects. Therefore, both castration and miR-29a over-expression mimicked the AR knockout-mediated epididymis agenesis.
Moreover, we further characterized the miR-29 and AR regulatory circuitry in epididymis by identifying IGF1 and p53 as critical mediators of the regulatory circuitry. As in the prostate (38) , IGF1 enhanced AR expression and was directly suppressed by miR-29a in mouse epididymis. Therefore, the suppression of miR-29a on AR might mediate or at least partially mediate by IGF1. Also, p53 bound to the promoter region of the AR gene to inhibit AR (40) . miR-29a elevated p53 by down regulation of CDC42 and p85α (41) . Herein, we demonstrated, in epididymis, miR-29a directly down-regulated CDC42 and p85α to promote p53, hence inhibited AR expression. 
